View the September/October digital edition of Imaging Technology News (ITN), including links to videos, comparison charts and related content. Free access to the digital edition Sign up for a free subscription This issue includes links to the following online content: A Change Is Coming Artificial

September 21, 2022 – Guerbet, a global medical imaging company, has announced that the U.S. Food and Drug Administration (FDA) after priority review, approved Elucirem (Gadopiclenol), a new macrocyclic GBCA for use in contrast-enhanced magnetic resonance imaging (MRI). According to a news release

September 20, 2022 — Children and adolescents who have either recovered from COVID-19 or have long COVID show persistent lung damage on MRI, according to a study published in Radiology, a journal of the Radiological Society of North America (RSNA). COVID-19 is an infectious disease caused by the

September 16, 2022 — The Radiological Society of North America (RSNA) has announced Technical Exhibits highlights for their 108th Scientific Assembly and Annual Meeting (RSNA 2022) held in Chicago at McCormick Place, Nov. 27 – Dec. 1. As the world’s largest annual medical imaging forum, RSNA 2022

“Lung cancer is the deadliest cancer in men and in women, and it all boils down to how it is detected and when it is diagnosed,” said Michael Wert, MD, director of The James Lung Cancer Screening Clinic at The Ohio State University Wexner Medical Center. Referencing screening programs, like the one